You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 156 No. 6, 25 MARCH 1996 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (37)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cholesterol Crystal Embolization in the Netherlands

A Review of 842 Cases Filed in the Dutch National Pathology Information System From 1973 Through 1994

Willem Moolenaar, MD; Cornelis B. H. W. Lamers, MD, PhD

Arch Intern Med. 1996;156(6):653-657.


Abstract

Objective
To clarify the incidence and clinical features of cholesterol crystal embolization (CCE).

Methods
Analysis of the relevant data of 842 diagnosed cases of CCE filed in the Dutch National Pathology Information System from 1973 through 1994.

Results
No report of CCE was recorded from 1973 through 1979. Since then, its incidence rose from 0.9 case per million population in 1980 to 6.0 cases per million population in 1985, but stabilized thereafter. Among autopsy reports, the relative percentage of CCE was similar over the years, with 0.35% in 1982 and 0.30% in 1994 (mean, 0.31%; range, 0.20% to 0.42%). Nine patients in whom CCE was found in their renal transplant were excluded from the study. Thus, among a total of 833 elderly (mean age, 72.1 years), predominantly male (73.9%) patients, 1066 CCE sites were found in 323 biopsy reports, 264 resection reports, and 287 autopsy reports.

Conclusions
In the Dutch population, CCE is reported steadily, with an average frequency of 6.2 cases per million population per year since 1985. It occurs predominantly in elderly men with a history of atherosclerotic disease and hypertension. Symptoms may be absent, go unrecognized, or mimic other disease processes. It can also be a coincidental finding. The primary CCE site is the kidney, followed by the skin and the gastrointestinal tract.

(Arch Intern Med. 1996;156:653-657)



Author Affiliations

From the Department of Internal Medicine, Wilhelmina Hospital, Assen, the Netherlands (Dr Moolenaar), and the Department of Gastroenterology and Hepatology, University Hospital, Leiden, the Netherlands (Dr Lamers).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Progressive acute kidney injury following myocardial infarction: cholesterol embolisation
Parmar
BMJ Case Reports 2009;2009:bcr0620080103-bcr0620080103.
ABSTRACT | FULL TEXT  

Atheromatous embolization
Liew and Bartholomew
Vasc Med 2005;10:309-326.
ABSTRACT  

Massive bowel infarction after percutaneous transluminal renal angioplasty
Ricciardi et al.
Nephrol Dial Transplant 2005;20:2259-2261.
FULL TEXT  

Lesson of the week: Cholesterol emboli syndrome
Dupont et al.
BMJ 2000;321:1065-1067.
FULL TEXT  

Atheroembolism or Cholesterol Crystal Embolization
Stehbens
Arch Intern Med 1997;157:244-245.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.